Skip to main content

Closed

IMA: ImageneBio Inc Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-61.8% / yr

Operating margin0.0%

ROIC-42.0%

Financially safe

Stretched

Debt / equity0.07×

Interest coverage-582.6×

Current ratio18.39×

ImageneBio Inc

IMANASDAQ Global Market·USD·Closed

ImageneBio Inc

IMANASDAQ·USD·Closed

$5.54

−6.26%

$5.54

−$0.37 (6.26%)

52W Range

11thpctl

Volume

0.31×avg

Mkt Cap

62.49MUSD

P/E

-1.2TTM

Div Yield

–ann

52W Range

11thpctl

Volume

0.31×avg

Market Cap

62.49MUSD

P/E Ratio

-1.2TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings